Streetbeat News

Products Services

ARQT

CVS

Arcutis Biotherapeutics announced that its product Zoryve (Roflumilast) Cream 0.3% for plaque psoriasis is now covered as a preferred tier product on CVS Caremark's largest national commercial formularies.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 12:05 pm

PDSB

PDS Biotechnology Corporation (NASDAQ:PDSB) announced that an abstract on interim data from a clinical trial evaluating the combination of PDS0301, an IL-12-based immunocytokine, with the chemotherapy medication docetaxel has been accepted for oral presentation at the 11th Annual Meeting of the International Cytokine & Interferon Society (Cytokines 2023). The trial is investigating the safety, immune responses and clinical activity of PDS0301 and docetaxel in metastatic castration-sensitive and castration-resistant prostate cancer patients.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 12:05 pm

ENVB

Enveric Biosciences has reported results from animal studies showing oral bioavailability and a well-tolerated side effect profile for EB-373. The results could potentially lead to further development and testing of the drug.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 12:04 pm

ICCM

IceCure Medical has expanded the distribution of its ProSense system into Portugal through an agreement with Medicinália Cormédica. The ProSense system is used for the treatment of benign and malignant tumors.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 12:03 pm

MDGL

Madrigal Pharmaceuticals has completed the rolling submission of its New Drug Application (NDA) to the FDA for Resmetirom, a treatment for NASH with liver fibrosis. The company has requested a priority review of the application.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 12:03 pm

JANX

Janux Therapeutics has announced interim clinical data from its Phase 1a dose escalation for PSMA-TRACTr JANX007 and an update on pipeline programs. The preliminary data showed encouraging safety results with no dose-limiting toxicities. The company will host a virtual investor event today at 4:00 PM Eastern Time.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 12:02 pm

BTCUSD

ETHUSD

Binance has integrated the Bitcoin Lightning Network on its platform for BTC withdrawals and deposits. This comes three months after Binance temporarily halted BTC withdrawals due to network congestion. The Lightning Network is a development aimed at enhancing the speed and cost efficiency of Bitcoin transactions. Coinbase CEO Brian Armstrong had previously indicated his intention to integrate the Bitcoin layer 2 network on Coinbase.

Portfolio Pulse from Mehab Qureshi

July 17, 2023 | 11:52 am

DNUT

Krispy Kreme Inc (NASDAQ:DNUT) has partnered with M&M'S to create four doughnuts. The new M&M'S collection will be available from July 17 for a limited time at participating shops across the U.S. DNUT shares closed lower by 0.71% at $15.35 on Friday.

Portfolio Pulse from Shivani Kumaresan

July 17, 2023 | 11:42 am

BBIO

BridgeBio's Phase 3 ATTRibute-CM study of acoramidis for transthyretin amyloid cardiomyopathy has met its primary endpoint, leading to a rise in the company's shares.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 11:41 am

QCOM

DigiTimes reports that Qualcomm (QCOM) and Mediatek are relying on India's handset recovery to clear their inventory. This suggests that the companies are expecting an increase in demand for their products in the Indian market.

Portfolio Pulse from Charles Gross

July 17, 2023 | 11:36 am